GM
44
4
QCOM
56
5
HIG
78
6
ZION
55
7
EW
32
-2
NOC
47
2
ORLY
62
9
V
46
2
NWSA
71
2
EQT
59
5
PRU
59
5
SIG
54
2
SYK
42
2
FE
64
4
PGR
68
4
R
61
4
FITB
58
5
COF
49
2
ADSK
43
3
O
39
2
GM
44
4
QCOM
56
5
HIG
78
6
ZION
55
7
EW
32
-2
NOC
47
2
ORLY
62
9
V
46
2
NWSA
71
2
EQT
59
5
PRU
59
5
SIG
54
2
SYK
42
2
FE
64
4
PGR
68
4
R
61
4
FITB
58
5
COF
49
2
ADSK
43
3
O
39
2
Financhill
Back

TG Therapeutics 10K Form

Buy
75

TGTX
TG Therapeutics

Last Price:
$40.77
Seasonality Move:
13.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TGTX News And Ratings

See the #1 stock for the next 7 days that we like better than TGTX

TGTX Financial Statistics

Sales & Book Value

Annual Sales: $329M
Cash Flow: $-25.7M
Price / Cash Flow: 53.48
Annual Sales: $1.43
Price / Book: 28.85

Profitability

EPS (TTM): 0.14000
Net Income (TTM): $23.4M
Gross Margin: $290.5M
Return on Equity: 12.81%
Return on Assets: 5.16%

TG Therapeutics Earnings Forecast

Key TG Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 29 years for TGTX is 88.30%.
  • The Selling, General & Administrative Expenses for TGTX have been equal to 46.90% of Gross Profit Margin.
  • The Research & Development expenses have been 28.66% of Revenue.
  • The Interest Expense is 102.76% of Operating Income.
  • The Net Earning history of TGTX is 7.11% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

TG Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TGTX
CUSIP: 88322Q
Website: tgtherapeutics.com

Debt

Debt-to-Equity Ratio: 1.1
Current Ratio: 6.25
Quick Ratio: 4.85

Price-to-Earnings

Trailing P/E Ratio: 272.27
Forward P/E Ratio: 21.44

TGTX Technical Analysis vs Fundamental Analysis

Buy
75
TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics a Buy or a Sell?

  • TG Therapeutics stock is rated a Buy
    The current TG Therapeutics [TGTX] share price is $40.84. The Score for TGTX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.